EWM
BSX icon

Evolution Wealth Management’s Boston Scientific BSX Stock Holding History

Evolution Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Sell
839
-44
-5% -$2.39K 0.02% 363
2026
Q1 		$55.4K Buy
883
+483
+121% +$38.6K 0.04% 256
2025
Q4 		$38.1K Buy
400
+102
+34% +$10K 0.03% 270
2025
Q3 		$29.1K Buy
298
+71
+31% +$7.35K 0.03% 257
2025
Q2 		$24.4K Buy
+227
New +$23K 0.03% 258

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Evolution Wealth Management's BSX Position: Q2 2026 in Review

Evolution Wealth Management reduced its Boston Scientific (BSX) stake by 5% in Q2 2026, selling an estimated $2.39K and leaving 839 shares worth $35.8K. The position accounts for 0.02% of the portfolio, ranked #363.

Evolution Wealth Management first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $55.4K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Evolution Wealth Management held 839 shares of Boston Scientific worth $35.8K as of Q2 2026.
  • Evolution Wealth Management sold 44 Boston Scientific shares in Q2 2026, an estimated $2.39K.
  • Boston Scientific made up 0.02% of Evolution Wealth Management's portfolio in Q2 2026, its #363 holding.
  • Evolution Wealth Management first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Evolution Wealth Management's Boston Scientific position peaked at $55.4K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.